Delivery Order SPE2DB20D3101-SPE2DB24FQTM5
- Not listed
- This is a $1,712.85 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of 4,565,308,592 units of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,453.62 firm fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.99 firm fixed-price delivery order covers the supply of 4,562,888,387 units of Fenofibrate 145 mg tablets. The award has an ultimate completion date of November 24, 2023 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,187.94 firm-fixed-price contract is for the delivery of 500 tablets of Fenofibrate 145 mg, a medication used to treat high cholesterol and triglycerides. The contract has an ultimate completion date of August 9, 2024, and is not designated as a set-aside. AmerisourceBergen holds several Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.62 delivery order is for the supply of Fenofibrate 48 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.74, is a Firm Fixed Price Delivery Order for the supply of Fenofibrate 48 mg Tablet Unit Dose (30s). The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,561.64 firm fixed price contract is for the delivery of fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,068.36, is for the supply of 4564160110 - Fenofibrate 145 mg tablets in 90-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 48 mg tablets. The contract has a ceiling value of $1,713.70 and is a firm fixed price delivery order with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for the delivery of a wide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of fenofibrate 145 mg tablets. The ceiling value of this order is $1,072.97. This award was not set aside for a specific business type. AmerisourceBergen is the prime contractor and no subcontractors were mentioned. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTM5Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,134.57 fixed-price contract is for the supply of Fenofibrate 145 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of October 26, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/25/23 |